Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (481-490 of 715) with videos related to

Pageof 72
Sort By:
Thrombosis and Haemostasis|October 28, 1987
Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activatorJ M Stassen, I Juhan-Vague, M C Alessi, et al.
Thrombosis and Haemostasis|July 6, 1992
Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivoD E Vaughan, P J Declerck, E Van Houtte, et al.
Blood|May 1, 1992
Thrombolytic and pharmacokinetic properties of an immunoconjugate of single-chain urokinase-type plasminogen activator (u-PA) and a bispecific monoclonal antibody against fibrin and against u-PA in baboonsY Imura, J M Stassen, T Kurokawa, et al.
Thrombosis and Haemostasis|February 12, 1991
Thrombolytic and pharmacokinetic properties of human tissue-type plasminogen activator variants, obtained by deletion and/or duplication of structural/functional domains, in a hamster pulmonary embolism modelD Collen, H R Lijnen, I Vanlinthout, et al.
Thrombosis and Haemostasis|February 28, 1989
Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis modelD Spriggs, H K Gold, Y Hashimoto, et al.
Circulation Research|December 1, 1990
In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activatorI K Jang, H K Gold, R C Leinbach, et al.
Thrombosis and Haemostasis|May 11, 1999
Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injuryH Matsuno, O Kozawa, M Niwa, et al.
European Journal of Biochemistry|January 1, 1991
Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimerF Bulens, A M Vandamme, H Bernar, et al.
European Journal of Biochemistry|September 24, 1990
Construction and characterization of a recombinant murine monoclonal antibody directed against human fibrin fragment-D dimerA M Vandamme, F Bulens, H Bernar, et al.
The Journal of Biological Chemistry|November 25, 1990
Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell cultureM A Shatos, J M Doherty, D C Stump, et al.
Pageof 72

Showing results (481-490 of 715) with videos related to

Sort By:
Pageof 72
Thrombosis and Haemostasis|October 28, 1987
Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activatorJ M Stassen, I Juhan-Vague, M C Alessi, et al.
Thrombosis and Haemostasis|July 6, 1992
Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivoD E Vaughan, P J Declerck, E Van Houtte, et al.
Blood|May 1, 1992
Thrombolytic and pharmacokinetic properties of an immunoconjugate of single-chain urokinase-type plasminogen activator (u-PA) and a bispecific monoclonal antibody against fibrin and against u-PA in baboonsY Imura, J M Stassen, T Kurokawa, et al.
Thrombosis and Haemostasis|February 12, 1991
Thrombolytic and pharmacokinetic properties of human tissue-type plasminogen activator variants, obtained by deletion and/or duplication of structural/functional domains, in a hamster pulmonary embolism modelD Collen, H R Lijnen, I Vanlinthout, et al.
Thrombosis and Haemostasis|February 28, 1989
Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis modelD Spriggs, H K Gold, Y Hashimoto, et al.
Circulation Research|December 1, 1990
In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activatorI K Jang, H K Gold, R C Leinbach, et al.
Thrombosis and Haemostasis|May 11, 1999
Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injuryH Matsuno, O Kozawa, M Niwa, et al.
European Journal of Biochemistry|January 1, 1991
Construction and characterization of a functional chimeric murine-human antibody directed against human fibrin fragment-D dimerF Bulens, A M Vandamme, H Bernar, et al.
European Journal of Biochemistry|September 24, 1990
Construction and characterization of a recombinant murine monoclonal antibody directed against human fibrin fragment-D dimerA M Vandamme, F Bulens, H Bernar, et al.
The Journal of Biological Chemistry|November 25, 1990
Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell cultureM A Shatos, J M Doherty, D C Stump, et al.
Pageof 72